rs42531
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000089.4(COL1A2):c.2565+233G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.28 in 545,616 control chromosomes in the GnomAD database, including 22,970 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.24 ( 5258 hom., cov: 31)
Exomes 𝑓: 0.30 ( 17712 hom. )
Consequence
COL1A2
NM_000089.4 intron
NM_000089.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.00500
Publications
8 publications found
Genes affected
COL1A2 (HGNC:2198): (collagen type I alpha 2 chain) This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
COL1A2 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndrome, arthrochalasia type, 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Illumina, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- osteogenesis imperfectaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- osteogenesis imperfecta type 1Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- osteogenesis imperfecta type 2Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen
- osteogenesis imperfecta type 3Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
- osteogenesis imperfecta type 4Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Ehlers-Danlos syndrome, arthrochalasia typeInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
- Ehlers-Danlos syndrome, cardiac valvular typeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, PanelApp Australia, Orphanet, G2P
- combined osteogenesis imperfecta and Ehlers-Danlos syndrome 2Inheritance: AD Classification: MODERATE Submitted by: ClinGen, Ambry Genetics
- Ehlers-Danlos/osteogenesis imperfecta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- high bone mass osteogenesis imperfectaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 7-94423351-G-A is Benign according to our data. Variant chr7-94423351-G-A is described in ClinVar as Benign. ClinVar VariationId is 1269568.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.307 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL1A2 | NM_000089.4 | c.2565+233G>A | intron_variant | Intron 40 of 51 | ENST00000297268.11 | NP_000080.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL1A2 | ENST00000297268.11 | c.2565+233G>A | intron_variant | Intron 40 of 51 | 1 | NM_000089.4 | ENSP00000297268.6 | |||
| COL1A2 | ENST00000481570.5 | n.881G>A | non_coding_transcript_exon_variant | Exon 1 of 8 | 2 | |||||
| COL1A2 | ENST00000497316.5 | n.*233G>A | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.237 AC: 36000AN: 151834Hom.: 5260 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
36000
AN:
151834
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.296 AC: 116582AN: 393662Hom.: 17712 Cov.: 4 AF XY: 0.296 AC XY: 62360AN XY: 210742 show subpopulations
GnomAD4 exome
AF:
AC:
116582
AN:
393662
Hom.:
Cov.:
4
AF XY:
AC XY:
62360
AN XY:
210742
show subpopulations
African (AFR)
AF:
AC:
627
AN:
11114
American (AMR)
AF:
AC:
4387
AN:
17538
Ashkenazi Jewish (ASJ)
AF:
AC:
3420
AN:
11618
East Asian (EAS)
AF:
AC:
6470
AN:
24614
South Asian (SAS)
AF:
AC:
12634
AN:
44652
European-Finnish (FIN)
AF:
AC:
7931
AN:
21824
Middle Eastern (MID)
AF:
AC:
408
AN:
1670
European-Non Finnish (NFE)
AF:
AC:
74496
AN:
238168
Other (OTH)
AF:
AC:
6209
AN:
22464
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
3982
7963
11945
15926
19908
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
398
796
1194
1592
1990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.237 AC: 35986AN: 151954Hom.: 5258 Cov.: 31 AF XY: 0.241 AC XY: 17927AN XY: 74278 show subpopulations
GnomAD4 genome
AF:
AC:
35986
AN:
151954
Hom.:
Cov.:
31
AF XY:
AC XY:
17927
AN XY:
74278
show subpopulations
African (AFR)
AF:
AC:
2535
AN:
41488
American (AMR)
AF:
AC:
3900
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
AC:
982
AN:
3470
East Asian (EAS)
AF:
AC:
1313
AN:
5146
South Asian (SAS)
AF:
AC:
1335
AN:
4820
European-Finnish (FIN)
AF:
AC:
3984
AN:
10546
Middle Eastern (MID)
AF:
AC:
73
AN:
294
European-Non Finnish (NFE)
AF:
AC:
21121
AN:
67918
Other (OTH)
AF:
AC:
485
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1303
2606
3908
5211
6514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
376
752
1128
1504
1880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
805
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 23, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.